The SAGE Oncotest™ Approach
Machine learning-enabled live 3D cancer profiling
1
We create live 3D microtumors of the patient’s sample in a day...
2
that retain the microenvironment and heterogeneity of the sample...
3
testing multiple drugs using our proprietary technologies...
4
to identify the most effective therapy in just one week.
By using the patient’s primary live cancer tissue rather than formalin-fixed tissue of dead cancer cells, the SAGE Oncotest™ empowers oncologists and patients to identify the most effective therapy, overcoming inherent limitations of genomic testing.
Furthermore, the SAGE Oncotest™ is faster and more reproducible than legacy live-cell assays and it overcomes the limitations of organoid models.